Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Eletriptan
Drug ID BADD_D00755
Description Eletriptan is a second generation triptan drug developed by Pfizer Inc for the treatment of migraine headaches.
Indications and Usage For the acute treatment of migraine with or without aura in adults.
Marketing Status approved; investigational
ATC Code N02CC06
DrugBank ID DB00216
KEGG ID D07887
MeSH ID C115647
PubChem ID 77993
TTD Drug ID D02DMQ
NDC Product Code Not Available
UNII 22QOO9B8KI
Synonyms eletriptan | (R)-3-((1-methyl-2-pyrrolidinyl)methyl)-5-(2-(phenylsulfonyl)ethyl)-1H-indole | UK 166,044 | UK-166044 | UK 166044 | UK-166,044 | Relpax | UK-116044-04 | UK-116,044-04 | eletriptan hydrobromide | (R)-3-((1-methyl-2-pyrrolidinyl)methyl)-5-(2-(phenylsulfonyl)ethyl)-1H-indole monohydrobromide | 3-(1-methyl-2-pyrrolidinylmethyl)-5-(2-(phenylsulfonyl)ethyl)-1H-indole hydrobromide
Chemical Information
Molecular Formula C22H26N2O2S
CAS Registry Number 143322-58-1
SMILES CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Back pain15.03.04.0050.001157%
Blindness06.02.10.003; 17.17.01.0030.000723%Not Available
Blood creatine phosphokinase increased13.04.01.001--
Blood pressure increased13.14.03.005--Not Available
Body temperature decreased13.15.01.010--Not Available
Body temperature increased13.15.01.001--Not Available
Bone neoplasm16.29.01.001; 15.09.02.001--Not Available
Bone pain15.02.01.001--
Bradycardia02.03.02.002--Not Available
Breast cancer16.10.01.001; 21.05.01.0030.000361%Not Available
Breast pain21.05.05.003--
Breath odour07.01.06.002--Not Available
Bronchitis22.07.01.001; 11.01.09.001--
Burning sensation08.01.09.029; 17.02.06.001--Not Available
Cardiac arrest02.03.04.0010.000361%
Cataract06.06.01.0010.000361%
Catatonia19.11.01.001--Not Available
Cerebral infarction24.04.06.002; 17.08.01.0040.000542%Not Available
Cerebrovascular disorder17.08.02.002; 24.03.05.002--Not Available
Chest discomfort22.12.02.002; 08.01.08.019; 02.02.02.0090.002494%Not Available
Chest pain22.12.02.003; 08.01.08.002; 02.02.02.0110.002674%Not Available
Chills08.01.09.001; 15.05.03.016--
Choking sensation22.12.03.004; 19.01.02.002--Not Available
Colitis ischaemic24.04.08.012; 07.08.01.0040.000361%Not Available
Condition aggravated08.01.03.0040.006361%Not Available
Confusional state17.02.03.005; 19.13.01.0010.001518%
Conjunctivitis11.01.06.012; 06.04.01.002--
Constipation07.02.02.001--
Conversion disorder19.24.01.001--Not Available
Coordination abnormal17.02.02.004--Not Available
The 2th Page    First    Pre   2 3 4 5 6    Next   Last    Total 10 Pages